Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Intermediate Risk Nasopharyngeal Carcinoma
NCT02633202Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Nov 2015; status: completed.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02633202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633202.